Alimera Sciences, Inc. (ALIM) Financials

ALIM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 153.5 million 107.4 million
2023-09-30 154.2 million 105.4 million
2023-06-30 154.9 million 108.7 million
2023-03-31 48.2 million 67.2 million

ALIM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 3.7 million 805000
2023-09-30 -9.8 million 188000
2023-06-30 -81.4 million 216000
2023-03-31 -2.2 million 226000

ALIM Net Income

No data available :(

ALIM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 12.1 million - 828000
2023-09-30 8.3 million - 193000
2023-06-30 18.8 million 64.0 million 203000
2023-03-31 13.1 million - 263000

ALIM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 54.4 million
2023-09-30 32.1 million
2023-06-30 8.1 million
2023-03-31 7.0 million

ALIM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 85000 4.8 million 6.4 million 7.8 million
2023-09-30 4000 4.0 million 3.6 million 7.9 million
2023-06-30 75.4 million 3.6 million 4.4 million 6.4 million
2023-03-31 9000 4.2 million 4.2 million 5.8 million

ALIM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 26.3 million 6.7 million
2023-09-30 23.4 million 2.8 million
2023-06-30 17.5 million 2.4 million
2023-03-31 13.5 million 2.0 million

ALIM

Price: $3.65

52 week price:
1.56
4.38

Earnings Per Share: -0.84 USD

P/E Ratio: -2.36

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 7882

Ebitda: -3.1 million

Market Capitalization: 191.2 million

Links: